Literature DB >> 14871038

Transfer of rabbit autoimmune cardiomyopathy into severe combined immunodeficiency mice.

Shinobu Matsui1, Michael Fu, Mituru Hayase, Shogo Katsuda, Nobuo Yamaguchi, Kohei Teraoka, Takayuki Kurihara, Noboru Takekoshi.   

Abstract

Growing evidence suggests that the autoimmune mechanism plays an important role in the pathogenesis of dilated cardiomyopathy. The purpose of this study was to evaluate the effect on the cardiac structure and function by the transfer of immunoglobulin G (IgG) and/or lymphocytes from rabbits immunized with a synthetic peptide corresponding to the sequence of the second extracellular loop of beta1-adrenoceptor (beta peptide) into severe combined immunodeficiency (SCID) mice. CB-17 SCID mice were injected intraperitoneally with 2 mg of IgG and/or 1 x 10(7) peripheral blood lymphocytes (PBL) from either rabbits immunized with both beta1 peptide and adjuvant (beta group), and adjuvant or rabbits with adjuvant only (N group). Thirty-five SCID mice were divided into seven groups: (1) N-IgG group; (2) N-PBL group; (3) N-IgG+PBL group; (4) beta-IgG group; (5) beta-PBL group; (6) beta-IgG+PBL group; and (7) control group. Morphological, serological and endocrinological studies were performed 70 days after the transfer. Results showed that heart weight and heart weight/body weight ratio in the beta-IgG+PBL group tended to be increased as compared with those in other groups. All mice in the beta-IgG group, two in the beta-PBL group and four in the beta-IgG+PBL group showed high titer of rabbit anti-beta1-adrenoceptor antibodies. Brain natriuretic peptide in the beta-IgG+PBL group showed a significant increase as compared with those in the control group and N-IgG+PBL. Pathohistologically, focal infiltration of inflammatory cells in the myocardium was observed in one mouse of the beta-IgG+PBL group. Rabbit CD3-positive T-lymphocytes in the myocardium were observed in two mice of the beta group. In conclusion, transfer of IgG and PBL from rabbits immunized with beta1 peptide was able to induce the early stages of myocardial damage in SCID mice. These data provide direct evidence that the autoimmune mechanism is important in the pathogenesis of dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14871038     DOI: 10.1097/00005344-200312001-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Autoimmune hypertensive syndrome.

Authors:  David C Kem; Xichun Yu; Eugene Patterson; Shijun Huang; Stavros Stavrakis; Bela Szabo; Leann Olansky; Jon McCauley; Madeleine W Cunningham
Journal:  Hypertension       Date:  2007-10-08       Impact factor: 10.190

Review 2.  Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.

Authors:  Gerd Wallukat; Ingolf Schimke
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

3.  Adoptive passive transfer of rabbit beta1-adrenoceptor peptide immune cardiomyopathy into the Rag2-/- mouse: participation of the ER stress.

Authors:  Jiahao Liu; Weike Mao; Chikao Iwai; Shuji Fukuoka; Raju Vulapalli; Huanlei Huang; Tingchung Wang; Virendra K Sharma; Shey-Shing Sheu; Michael Fu; Chang-Seng Liang
Journal:  J Mol Cell Cardiol       Date:  2007-11-24       Impact factor: 5.000

4.  Animal models of cardiac disease and stem cell therapy.

Authors:  Lailiang Ou; Wenzhong Li; Yi Liu; Yue Zhang; Shen Jie; Deling Kong; Gustav Steinhoff; Nan Ma
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

5.  T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.

Authors:  Katja Bieber; Mareike Witte; Shijie Sun; Jennifer E Hundt; Kathrin Kalies; Sören Dräger; Anika Kasprick; Trix Twelkmeyer; Rudolf A Manz; Peter König; Jörg Köhl; Detlef Zillikens; Ralf J Ludwig
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

6.  Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy.

Authors:  Katrin Wenzel; Sarah Schulze-Rothe; Annekathrin Haberland; Johannes Müller; Gerd Wallukat; Hanna Davideit
Journal:  Heliyon       Date:  2017-07-31

7.  Autoantibody against β1-adrenoceptor promotes the differentiation of natural regulatory T cells from activated CD4+ T cells by up-regulating AMPK-mediated fatty acid oxidation.

Authors:  Wenli Xu; Ye Wu; Li Wang; Yan Bai; Yunhui Du; Yang Li; Ning Cao; Yuhui Zhao; Youyi Zhang; Huirong Liu
Journal:  Cell Death Dis       Date:  2019-02-15       Impact factor: 8.469

8.  Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure.

Authors:  Uichi Ikeda; Hiroki Kasai; Atsushi Izawa; Jun Koyama; Yoshikazu Yazaki; Masafumi Takahashi; Makoto Higuchi; Chang-Sung Koh; Keiji Yamamoto
Journal:  Curr Cardiol Rev       Date:  2008-08

9.  The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomes.

Authors:  Sabine Werner; Gerd Wallukat; Niels-Peter Becker; Katrin Wenzel; Johannes Müller; Ingolf Schimke; Gerhard Wess
Journal:  ESC Heart Fail       Date:  2020-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.